Positive Crossmatch Kidney Transplant Recipients Treated With Eculizumab: Outcomes Beyond 1 Year
Top Cited Papers
Open Access
- 1 May 2015
- journal article
- clinical trial
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 15 (5), 1293-1302
- https://doi.org/10.1111/ajt.13168
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Health (DK 088791)
This publication has 32 references indexed in Scilit:
- Kidney Allograft Survival After Acute Rejection, the Value of Follow-Up BiopsiesAmerican Journal of Transplantation, 2013
- A Novel Pathway of Chronic Allograft Rejection Mediated by NK Cells and AlloantibodyAmerican Journal of Transplantation, 2011
- Desensitization in HLA-Incompatible Kidney Recipients and SurvivalThe New England Journal of Medicine, 2011
- Calculated PRA: Initial Results Show Benefits for Sensitized Patients and a Reduction in Positive CrossmatchesAmerican Journal of Transplantation, 2011
- Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney TransplantationJournal of the American Society of Nephrology, 2010
- The role of the anaphylatoxins in health and diseaseMolecular Immunology, 2009
- Banff ’05 Meeting Report: Differential Diagnosis of Chronic Allograft Injury and Elimination of Chronic Allograft Nephropathy (’CAN’)American Journal of Transplantation, 2007
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999
- Anti-HLA antibody ligation to HLA class I molecules expressed by endothelial cells stimulates tyrosine phosphorylation, inositol phosphate generation, and proliferationHuman Immunology, 1997
- Inhibition of complement activity by humanized anti-C5 antibody and single-chain FvMolecular Immunology, 1996